EPHA7 (580-end), actif, GST étiqueté à partir de la souris, PRECISIO Kinase, recombinant, exprimé en cellules baculovirus infectées Sf9, >=70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5233-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

EPHA7 is a member of the ephrin receptor subfamily of protein-tyrosine kinases family that have been implicated in mediating developmental events, particu...


en savoir plus

Votre prix
$564.93 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

EPHA7 is a member of the ephrin receptor subfamily of protein-tyrosine kinases family that have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2-fibronectin types III repeats. EPHA7 mediated signaling act as a physiologic trigger for apoptosis that can alter brain size and shape by regulating the number of neural progenitors. The high expression of EPHA7 protein plays an important role in the malignancy transformation, invasion progression and metastasis of primary hepatocellular carcinoma.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationmouse ... Epha7(13841)
mol wt~73 kDa
NCBI accession no.BC026153
product linePRECISIO® Kinase
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity30-40 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: